The government has explicitly targeted a specific religious group, categorically labeling it a “social harm” and a “detriment” while mobilizing state power in a retaliatory manner. Such actions constitute a grave violation of Article 20 of the Constitution of the Republic of Korea, which guarantees the freedom of religion and the principle of the separation of church and state. The Shincheonji Church of Jesus expresses profound concern over this unilateral interference by state power and strongly urges the administration to uphold the principles of fair, restrained, and constitutional governance.

On 12 January, President Lee Jae-Myung stated during a meeting with religious leaders that “societal harm [caused by a specific religion] has been neglected for too long, resulting in great damage.” This was followed on 13 January by Prime Minister Kim Min-seok, who, during a Cabinet meeting, utilized terms such as “cult” and “heresy” to order a joint investigation and “eradication” measures.

These statements effectively draw a conclusion before any formal investigation has begun. Such rhetoric from the head of the executive branch preemptively brands a specific religious group as a “socially problematic entity,” which could be interpreted as compromising the due process and principles of the investigative process.

While a government-mandated joint investigation is underway, the administration is blatantly dismantling constitutional boundaries by declaring the group a “cult” and a “harm” as a foregone conclusion. By what authority does a secular government define and judge religious doctrine? On what legal basis does the highest seat of power provide “investigative guidelines” that undermine the independence of the judiciary?

The criteria for “orthodoxy” or “heresy” must never be based on political proximity or secular interests; they must be rooted solely in the Holy Scriptures.

History repeats itself. Two thousand years ago, Jesus Christ was branded a “heretic” and persecuted by the religious establishment of his time. Yet, history has vindicated Jesus as the cornerstone of the faith. Similarly, is it justifiable to label a religious body “heretical” based on congregation size or the assertions of rival pastors rather than the content of the Bible today?

With due regard for the issue, the Shincheonji Church of Jesus has repeatedly proposed a transparent solution: let us resolve these theological disputes through an open, public Bible examination, grounded in the Holy Scripture rather than emotion or political pressure. To date, there has been no fair response to this invitation.

Shincheonji Church of Jesus has never claimed infallibility. If there are genuine doctrinal or social errors, we ask that they be identified with specificity. We are committed to correcting any faults and have consistently maintained this stance. The Bible’s teachings guide our actions as we strive to become upright believers respected in our communities. From voluntary service during national disasters to leading record-breaking blood drives during supply crises, we have sought to be a vital part of society. Despite this, the government continues to use abstract labels such as “harm” without presenting a single specific instance of verified damage.

Furthermore, despite numerous past allegations, the judicial process has repeatedly resulted in acquittals or findings of no suspicion. Recycling matters already settled by the courts as fuel for political and media attacks only leads spectators and all parties involved to question whether it reflects what the Republic of Korea stands for or marks a departure from the standards of a democratic state governed by the rule of law.

The President and the political establishment must move away from the politics of scapegoating and toward a politics of unity that serves all the people they represent. Attempts to use religious establishments to evade political risks, or to weaponize majority opinion to suppress a minority religion, serve neither national development nor democracy. The State has a duty to ensure that no citizen is ostracized or discriminated against on the basis of their faith.

If one religion is targeted today, any marginalized group could be the target tomorrow. The Shincheonji Church of Jesus will stand firm in truth and faith within the framework of law and order, and will not be silenced, affirming its constitutional right to freedom of religion. We call upon the government to cease emotional branding, base its judgments on facts and law, and return to its fundamental duty of serving all people equally.

The members of Shincheonji Church of Jesus have always been sincere as people of the Republic of Korea. They have shown it through their actions, including cooperating with authorities in a collaborative spirit, engaging in unsparing volunteerism, and donating blood that saved lives. As people of faith who believe in God and Jesus, and as people of this nation, the church members will continue to live up to who they are as they always have.

NEW DELHI, INDIA — January 20, 2026 — StyleBuddy, India’s premier fashion styling services company, today officially announced the launch of the “Sabse Stylish Kaun” Challenge 2026. This nationwide competition aims to discover and celebrate India’s most unique fashion identities, offering a grand prize of ₹1,00,000 and professional styling opportunities.

In a first-of-its-kind initiative, StyleBuddy is democratizing high-end fashion by providing every participant with a Personalized Style Look created by expert stylists for a nominal fee of ₹499. This ensures that every entrant, regardless of their fashion background, has access to professional advice before competing for the top title.

The core intent of the “Sabse Stylish Kaun” Challenge is to bridge the gap between aspirational fashion and everyday wear. By moving beyond traditional modeling standards, StyleBuddy aims to empower individuals from all walks of life to discover their “Signature Style.” The competition serves as a catalyst for self-expression, encouraging participants to break free from cookie-cutter trends and embrace a wardrobe that truly reflects their inner personality.

To ensure a diverse and inclusive platform, the competition features multiple categories tailored to the rich sartorial landscape of India. Participants can compete in dedicated segments for Men and Women, with specialized awards spanning Western Wear, Formal Wear, and Indian Ethnic Wear. This categorized approach allows individuals to showcase their expertise in their preferred style genre, whether it be the sharp lines of a corporate suit, the contemporary flair of global trends, or the timeless elegance of traditional Indian craftsmanship.

For participants, joining the challenge offers more than just a chance at the cash prize; it provides an educational masterclass in personal branding. Each entrant walks away with a professional style blueprint that they can use long after the competition ends. Whether for professional networking, social media presence, or personal confidence, the expert-curated looks provide a lifelong toolset for navigating the world with style and poise.

Priya Rajesh, COO at StyleBuddy, commented on the launch:

“At StyleBuddy, we believe that style is a powerful form of self-communication that should be accessible to everyone, not just the elite. Through this competition, our goal is to ignite a style revolution across India. We aren’t just giving away a prize; we are giving participants the professional guidance they need to transform their self-image. We want every person who enters to feel like the most stylish version of themselves from the moment they receive their personalized look.”

Competition Highlights:

  • Grand Prize: ₹1,00,000 Cash Award and the “Most Stylish Person 2026” Trophy.
  • Runner-up: ₹50,000 Cash Award and Trophy.
  • Special Category Awards: Recognition for excellence in Men’s & Women’s Western, Formal, and Indian Ethnic Wear.
  • Professional Edge: Every participant receives a bespoke style guide from StyleBuddy’s panel of expert fashion stylists.
  • Eligibility: Open to all Indian residents aged 18 and above.
  • Deadline: Entries close on February 15, 2026.

The winners will be selected by an esteemed jury based on creativity, presentation, and the ability to carry a personalized look with confidence. Results will be announced on March 1, 2026. Interested participants can register and get their personalized looks at www.stylebuddy.fashion

About StyleBuddy:

StyleBuddy is India’s leading personal styling platform, dedicated to making professional fashion advice accessible to everyone. With a network of top-tier stylists, StyleBuddy provides wardrobe management, personal shopping, and style consultations to help individuals look and feel their best.

Chennai, January 20: The Rotary Club of Madras South (RCMS) marked a significant milestone in its community healthcare initiatives by donating two advanced pediatric ventilators to the Institute of Child Health (ICH), Egmore, under its flagship project aptly titled “Save Lives.”

The ventilators were formally handed over during a ceremonial event held at the ICH Auditorium, in the distinguished presence of District Governor Rtn. Vinoth Saraogi (District 3234). The occasion was further graced by RCMS President Rtn. R. Rajanbabu, Secretary Rtn. Sibi Rajan, and Rtn. K. Saravanan, Director – Community Services Health, in the presence of few more rotarians & Ann’s from RCMS, who officially handed over the equipment.

The hospital leadership was represented by Dr. Madhivanan, Director of Health, ICH, and Dr. G. K. Jaikaran, Professor and Head, Paediatric Cardiothoracic and Vascular Surgery, ICH, who acknowledged the timely and impactful contribution that will significantly strengthen pediatric critical care services at the institution.

Demonstrating a deep commitment beyond equipment donation, RCMS has ensured a comprehensive 5-year Annual Maintenance Contract (AMC) for both ventilators and has also set aside dedicated funds to address any unforeseen repair or operational expenses. This thoughtful approach ensures uninterrupted, long-term functionality of the life-saving equipment.

Speaking on the occasion, RCMS leaders emphasized that the “Save Lives” project stands as one of the most prestigious and meaningful initiatives of RCMS in the current Rotary year, reflecting the club’s sustained focus on child healthcare and preventive support systems.

“This initiative goes beyond a donation—it is a promise of continuity, care, and responsibility towards saving young lives,” said a senior RCMS office bearer.

With this project, Rotary Club of Madras South once again reaffirmed its commitment to Rotary International’s theme “Unite for Good,” reinforcing the belief that impactful service, when thoughtfully executed, can truly transform lives.

For media enquiries, please contact:
Balamurugan S
Chairman – Public Image
rtnbalasubbiah@gmail.com

CHHATRAPATI SAMBHAJINAGAR, January 20, 2026 – To commemorate National Startup Week and celebrate National Startup Day—observed annually on January 16th since 2023—the Marathwada Accelerator for Growth and Incubation Council (MAGIC) organized a landmark event today. The gathering proved to be a pivotal moment for the region’s entrepreneurial landscape, bringing together key stakeholders to celebrate the ever-growing startup ecosystem.

The highlight of the event was the official launch of the book authored by Umesh Rathod, (Founder Lean Campus Startups, 3 time TEDx Speaker, Startup Mentor to 4.75 lac students) titled, “Startup Theories, Examples and Activities” and the unveiling of the latest issue of MAGIC Incubator Newsletter “Discover MAGIC”. These resources are designed to provide practical guidance and updates to the region’s budding entrepreneurs.

The author highlighted the role of Incubators in tier 1 and tier 2 cities for providing opportunities to young entrepreneurs who have no option to migrate to other ecosystems. He stressed upon the need to look at support job creators in the academic setting i.e. students and faculties for providing them handholding and mentoring at the right time so they can prosper.

The event was graced by distinguished dignitaries, including:

  • Dr. Anil Sahasrabudhe Ex.Chairman AICTE, Hon. Chief Guest.
  • Dr. Vinod M. Mohitkar, Director of Technical Education (DTE).GoM
  • Dr. K. V. Kale, Vice Chancellor of DBATU University, Lonere
  • Mr. Umesh Rathod, AICTE Indovation Head, Western Region.
  • Mr. Munish Sharma, Director General of MIT CSN
  • Mr. Ashish Garde, Director of MAGIC.

The session featured a keynote address by Dr. Anil Sahasrabudhe, who shared insights into the future of innovation and the role of academic institutions in fostering entrepreneurship. Mr. Ashish Garde delivered the welcome address and presented a MAGIC PPT, detailing the incubator’s mission and achievements.

The event saw enthusiastic participation from a wide range of stakeholders, including:

  • Heads of Higher Education Institutions (HEIs).
  • Industry Leaders.
  • CEOs of various Incubators.
  • Academic Faculty and Students.

The proceedings concluded with a formal vote of thanks delivered by Mr. Nilesh Patil, Director of MIT.

About MAGIC Incubator:

MAGIC is a dedicated sector-agnostic business incubator based in Chhatrapati Sambhajinagar, focused on mentoring and accelerating the growth of early-stage startups through industry-academic collaboration.

www.umeshrathod.in | www.instagram.com/umesh_rathore | https://www.linkedin.com/in/umeshrathod

The government has explicitly targeted a specific religious group, categorically labeling it a “social harm” and a “detriment” while mobilizing state power in a retaliatory manner. Such actions constitute a grave violation of Article 20 of the Constitution of the Republic of Korea, which guarantees the freedom of religion and the principle of the separation of church and state. The Shincheonji Church of Jesus expresses profound concern over this unilateral interference by state power and strongly urges the administration to uphold the principles of fair, restrained, and constitutional governance.

On 12 January, President Lee Jae-myung stated during a meeting with religious leaders that “societal harm [caused by a specific religion] has been neglected for too long, resulting in great damage.” This was followed on 13 January by Prime Minister Kim Min-seok, who, during a Cabinet meeting, utilized terms such as “cult” and “heresy” to order a joint investigation and “eradication” measures.

These statements effectively draw a conclusion before any formal investigation has begun. Such rhetoric from the head of the executive branch preemptively brands a specific religious group as a “socially problematic entity,” which could be interpreted as compromising the due process and principles of the investigative process.

While a government-mandated joint investigation is underway, the administration is blatantly dismantling constitutional boundaries by declaring the group a “cult” and a “harm” as a foregone conclusion. By what authority does a secular government define and judge religious doctrine? On what legal basis does the highest seat of power provide “investigative guidelines” that undermine the independence of the judiciary?

The criteria for “orthodoxy” or “heresy” must never be based on political proximity or secular interests; they must be rooted solely in the Holy Scriptures.

History repeats itself. Two thousand years ago, Jesus Christ was branded a “heretic” and persecuted by the religious establishment of his time. Yet, history has vindicated Jesus as the cornerstone of the faith. Similarly, is it justifiable to label a religious body “heretical” based on congregation size or the assertions of rival pastors rather than the content of the Bible today?

With due regard for the issue, the Shincheonji Church of Jesus has repeatedly proposed a transparent solution: let us resolve these theological disputes through an open, public Bible examination, grounded in the Holy Scripture rather than emotion or political pressure. To date, there has been no fair response to this invitation.

Shincheonji Church of Jesus has never claimed infallibility. If there are genuine doctrinal or social errors, we ask that they be identified with specificity. We are committed to correcting any faults and have consistently maintained this stance. The Bible’s teachings guide our actions as we strive to become upright believers respected in our communities. From voluntary service during national disasters to leading record-breaking blood drives during supply crises, we have sought to be a vital part of society. Despite this, the government continues to use abstract labels such as “harm” without presenting a single specific instance of verified damage.

Furthermore, despite numerous past allegations, the judicial process has repeatedly resulted in acquittals or findings of no suspicion. Recycling matters already settled by the courts as fuel for political and media attacks only leads spectators and all parties involved to question whether it reflects what the Republic of Korea stands for or marks a departure from the standards of a democratic state governed by the rule of law.

The President and the political establishment must move away from the politics of scapegoating and toward a politics of unity that serves all the people they represent. Attempts to use religious establishments to evade political risks, or to weaponize majority opinion to suppress a minority religion, serve neither national development nor democracy. The State has a duty to ensure that no citizen is ostracized or discriminated against on the basis of their faith.

If one religion is targeted today, any marginalized group could be the target tomorrow. The Shincheonji Church of Jesus will stand firm in truth and faith within the framework of law and order, and will not be silenced, affirming its constitutional right to freedom of religion. We call upon the government to cease emotional branding, base its judgments on facts and law, and return to its fundamental duty of serving all people equally.

The members of Shincheonji Church of Jesus have always been sincere as people of the Republic of Korea. They have shown it through their actions, including cooperating with authorities in a collaborative spirit, engaging in unsparing volunteerism, and donating blood that saved lives. As people of faith who believe in God and Jesus, and as people of this nation, the church members will continue to live up to who they are as they always have.

13 January 2026

Members of Shincheonji Church of Jesus

Disclaimer:
This article is a statement issued by the Shincheonji Church of Jesus and reflects the views, opinions, and positions of its members. The content is provided for informational purposes only and does not necessarily represent the views of the publisher, editors, or affiliated parties. The publisher does not independently verify all claims made herein and encourages readers to form their own conclusions based on a broad range of sources. References to individuals, institutions, or government actions are presented as part of the organization’s expressed perspective.

New Delhi [India], January 19, 2026: VCCEdge, India’s leading private market research platform, and Candle Partners, one of the leading homegrown mid-market Investment Banks in India, have released the 17th edition of India’s Dealscape, an annual deals report capturing how India’s alternate investment ecosystem recalibrated through 2025.

Based on proprietary VCCEdge data tracked until November 2025, the report analyses trends across Private Equity (PE), Venture Capital (VC), Funds, Exits, Mergers & Acquisitions (M&A), and Equity Capital Markets (ECM), capturing a year marked by lower deal volumes but sharper capital concentration.

In addition to its data-driven analysis, the report features in-depth interviews with senior investment leaders, including:

  • Sunish Sharma, Founder and Managing Partner, Kedara Capital
  • Vishal Tulsyan, Founder & Executive Chairman, Motilal Oswal Alternates
  • Nishit Garg, Partner, Asia Investment Team, RTP Global

These interviews offer perspectives on capital deployment, exit planning, and how investors are adapting strategies in a more disciplined private markets environment.

The report also features a dedicated thought leadership article by Mr. Navroz Mahudawala, Managing Director, Candle Partners, examining the key factors shaping M&A activity in family-managed businesses, with insights into both current market dynamics and emerging trends.

To get access to the report, click here.

Private Equity: Deal Volumes Fall 21%, Capital Concentrates in Larger Bets

Private equity investments in India moderated further in 2025, with deal volumes declining 21% year-on-year, even as disclosed deal value rose 14%, signalling a clear shift toward fewer, larger transactions. Capital increasingly concentrated behind later-stage and pre-IPO companies, while Angel and Seed investments fell to 55% of total deal volumes, down sharply from recent years, reflecting tighter scrutiny around validation and profitability.

B2B companies accounted for over 53% of PE deal volumes in 2025, up from 46% in 2023, reinforcing investor preference for scalable and sustainable business models.

“What we are seeing is not a retreat from private markets, but a recalibration,” said Anitesh Dharam, Business Head, VCCEdge. “Capital in 2025 has become more selective, backing fewer opportunities but with stronger conviction, as investors prioritise durability and exit visibility over rapid deployment.”

Sector-wise, Information Technology remained the largest contributor to PE deal volumes in 2025, even as overall activity moderated. Healthcare and Consumer Discretionary saw a pronounced decline in deal volumes compared to 2024, reflecting tighter underwriting and greater focus on profitability and cash flows.

At a thematic level, the report highlights a clear shift within India’s new-age sectors. FinTech, HealthTech and MediaTech recorded steep declines in deal volumes, visible across themes.

Across the top three themes, funding activity softened from 2024 to 2025 while business model mixes largely remained unchanged. Retail/Ecommerce continued to be overwhelmingly B2C-led, FinTech retained its B2B skew despite lower volumes, and HealthTech saw the sharpest, broad-based contraction across B2B, B2C and hybrid models.

Venture Capital: Early-Stage Activity Remains Subdued

Venture capital investments remained cautious through 2025, with early-stage deal volumes staying under pressure. Series A volumes fell 21% and Series B 16%, while later rounds showed promise. Series C rose and Series D increased 39% and 71%, but off a low base as investors focused on companies with established revenues and longer operating histories, reinforcing the broader shift toward disciplined capital deployment.
In Value terms, Series E+ value dropped 47%, while Series A and B values softened in 2025.

PE Funds: Fewer Launches, Capital Raising Tightens

Private equity fund activity reflected the broader tightening in capital supply during 2025. The number of PE funds launched declined 37% year-on-year, while total targeted capital fell 6%, pointing to a more cautious fund formation environment.

The decline was sharper in VC Funds, with 62% decline in fund launches compared to 2024.

Fundraising outcomes were similarly selective. The number of PE funds that raised capital declined 25% in 2025, while the amount raised dropped 56%, underscoring heightened LP scrutiny and longer capital-raising cycles. Smaller funds continued to dominate launches, even as large-ticket fund formations remained limited, reinforcing a preference for proven strategies and managers.

VC fundraising followed a similar trajectory, with the number of VC funds raising capital falling 50% in 2025, reflecting sustained pressure on early-stage capital formation.

PE Exits: Exit Volumes Hit a Five-Year Low

Private equity exits declined to a five-year low by volume in 2025, reflecting valuation challenges and extended exit timelines. Exit value, however, remained broadly stable, indicating a continued focus on larger, selective monetisation events.

Open Market exits remained the dominant exit route by volume, even as activity slowed from 2024 levels. Public Offering (IPO) and Secondary Sale routes posted volume growth of 50% and 26% albeit on a lower base.

While Exit Activity declined during the five-year period, partial exits increased their share of total exits from 33% in 2021 to 43% in 2024, underscoring the growing use of staggered exit strategies by investors.

In 2025, Information Technology and Healthcare were the top sectors by PE exit volume, together accounting for nearly half of all deals, while Industrials stood out on value.

M&A Rebounds as Strategic Confidence Returns

India’s M&A market recorded a recovery in 2025, with deal volumes rising 22% year-on-year and deal value increasing 16%, signalling renewed confidence among corporates. Domestic transactions continued to dominate, accounting for nearly three-fourths of all M&A deals.

Healthcare led the M&A volume rebound in 2025 with an 82% YoY increase, even as PE funding into the sector remained tight, pointing to consolidation-led growth. On value, Financials (+51% YoY) and IT (+67% YoY) drove the upswing, alongside a sharp rise in Healthcare deal value (+68% YoY).

Equity Capital Markets Cool After a Record 2024

After a record-setting 2024, India’s equity capital markets entered a phase of recalibration in 2025. ECM deal volumes declined 31%, while deal value fell 38%, reflecting more selective issuance conditions.

IPOs remained the dominant ECM instrument, accounting for over 70% of ECM deal volumes, even as issuance became more tightly priced. $100 million-plus IPOs contributed over 80% of total IPO value, underscoring growing selectivity in public markets.

A Maturing Market, Not a Retreat

Taken together, India’s Dealscape 2025 highlights a private markets ecosystem that is structurally maturing. Lower deal volumes, fewer exits and tighter fundraising reflect a shift toward quality, patience and realistic exit planning, as selectivity — rather than speed — defines the current investment cycle.

About Candle Partners

Founded in 2010, Candle Partners is recognised as one of the leading home grown mid-market Investment Banks in India (with typical deal sizes in the Rs 100-500 crore bracket). Since its inception, Candle has achieved closure of 55+ transactions with key focus being sell side M&A (i.e. representing several family managed businesses in exiting / getting a strategic partner on board). The firm advises companies on fund raises, strategic acquisitions, divestments and majority stake transactions. In 2025, it acted as sole financial advisor for Harsoria Healthcare’s fund raise from Tata Capital, Radhesham Wellpack’s majority stake sale to JK Paper, and Thomas Assessments India’s acquisition by CIEL HR Services. Candle Partners has a 9-member team based in Mumbai, with the majority of team members bringing a wealth of IB & Big-4 experience.

Website: https://candleadvisors.com/

LinkedIn: https://in.linkedin.com/company/candle-advisors

About VCCEdge

VCCEdge is India’s premier financial research platform providing comprehensive data and insights across Private Equity, Venture Capital, M&A, Equity Capital Markets, and Funds. The platform supports deal origination, valuation, due diligence, and competitive intelligence through detailed company profiles, transaction data, and investor tracking.

LinkedIn: https://www.linkedin.com/company/vccedge1

Experience VCCEdge with a personalised demo: www.vccedge.com

New Delhi [India], January 16: We are calling all Class 10 CBSE students online to equip students with the knowledge and confidence to excel in their exams and beyond. Pankaj Sir has become a trusted name in the education industry with a proven track record of empowering students to achieve exceptional results. Elevate your Math skills to new heights this summer with an exclusive opportunity.

Enrollment for the Fresh Batches is now open, and limited seats are available (Intotal 50 seats).

Interested students and parents are encouraged to reach out to secure their spot and unlock the path to Maths mastery.

Pankaj Sir is known for his comprehensive teaching approach and passion for student success. He has transformed how students perceive and conquer the challenges of Maths.

  • Armaan (LPS Lucknow): Improved from 85% to 94%.
  • Shashwat (Venkaeshwar School, Dwarka): Advanced from 95% to 98%.
  • Tanmay (DPS KR Puram): Achieved remarkable growth from 79% to 91%.
  • Mohitha (Euroschool, Bangalore): Made significant progress from 78% to 88%.

In the upcoming fresh Batch, students will have the opportunity to:

1. Master CBSE Syllabus: Pankaj Sir will guide students through the entire grade 10 CBSE Maths syllabus, ensuring a solid foundation in each topic and covering all essential concepts clearly and engagingly.

2. Exam-focused Approach: With the board exams in mind, Pankaj Sir will provide valuable insights into exam patterns, question-solving techniques, and time management strategies to boost confidence and maximize scores.

3. Personalized Attention: Recognizing that each student has unique learning needs, Pankaj Sir will provide individualized attention, addressing doubts and clarifying concepts to ensure every student grasps the subject matter effectively.

4. Interactive Learning Experience: Every Batch will feature interactive sessions, group discussions, and problem-solving exercises to foster active participation and enhance students’ analytical thinking and problem-solving skills.

5. Exclusive Study Material: Students will receive meticulously curated study material, including comprehensive notes, practice worksheets, and 10 previous years’ question papers, enabling them to practice and reinforce their learning.

“Maths need not be an obstacle; it can be your stepping stone to success. Join me in this transformative Fresh Batch, where we will demystify Maths and build a strong foundation for your academic journey,” quoting Pankaj Sir.

About Pankaj Sir: Pankaj Sir is a highly respected educator specializing in CBSE Maths. He has mentored 1470+ students from Delhi, Bangalore, UAE, Qatar, Kuala Lumpur, in helping them achieve remarkable exam results. Pankaj Sir’s teaching approach combines in-depth subject knowledge, innovative teaching techniques, and personalized guidance to inspire students and ignite their passion for learning.

Whether you need help with homework or online tuition for CBSE class 10 or want to improve your Math skills, he’s here to help you every step of the way to help you reach your full potential.

  • 80% students score more than 90% in 10th math.
  • Worked at Vedantu, Cuemath, Meritnation (12 years exp)
  • Taught Toppers from DPS, DAV, KVS & NPS Bangalore

For media inquiries, please contact the following: Phone Number: +91- 9729040481.

Book a FREE demo here: https://mastermath.in

Join this fun and engaging Math learning journey now!

About The Company

Mastermath – Get excellent online Maths tuition for Class 10 CBSE from top tutor. Master the subject with personalized classes and score higher in exams. Enroll now!

Kolkata, January 2026: iTech, East India’s largest Apple Authorised Reseller, has announced its Republic Day Special Offers on the complete Apple portfolio, including iPhone, Mac, iPad, Apple Watch and accessories, across all 33 iTech stores in Eastern India.

The Republic Day campaign will run from January 19 to January 31, offering customers attractive pricing, exchange-led benefits and easy financing options—making it an ideal time to upgrade to Apple devices.

As part of the Republic Day offers, customers can avail:

  • Exchange benefits up to ₹35,000, along with an additional Exchange Bonus up to ₹10,000
  • Up to ₹4,000 instant cashback on select credit cards
  • No Cost EMI options up to 24 months
  • FREE Bluetooth Speaker + Power Bank worth ₹17,990* on select iPhone models
  • Special pricing across popular iPhone models, including the latest iPhone series

Speaking on the Republic Day campaign, Udit Dokania, Founder & CEO, iTech, said:

“Republic Day is a time to celebrate progress and aspiration. With our Republic Day offers, we are bringing together strong exchange value, flexible payment options and meaningful add-ons to make Apple products more accessible to customers across Eastern India. As we continue to expand our footprint, our focus remains on delivering a superior Apple buying experience across every iTech store.”

iTech operates a fast-growing network of Apple Premium stores across West Bengal, Bihar, Jharkhand, Odisha, Assam, Arunachal Pradesh, Nagaland and Uttar Pradesh, reinforcing its position as a trusted Apple retail partner in the region.

For more details on Republic Day offers and store locations, customers can visit www.itechstore.co.in or contact 033-40587597.

Noida, India — 15 January, 2026 – Ikris Pharma Network announced the availability of Triokris™ (Trientine Dihydrochloride 250 mg Capsules), a therapeutic option for patients diagnosed with Wilson’s Disease, a rare inherited disorder of copper metabolism. Triokris is designed to support clinicians in the management of patients requiring chelation therapy, especially in cases where first-line agents are contraindicated or not tolerated.

Wilson’s Disease is a progressive condition that, if untreated, can lead to severe hepatic, neurological, and psychiatric complications due to toxic copper accumulation. Early diagnosis and long-term treatment are critical for achieving meaningful clinical outcomes.

Triokris (Trientine Dihydrochloride) is recognized internationally as a well-established chelating agent with a long-standing clinical history. It is widely used across the United States, Europe, India, and multiple global regions for the management of Wilson’s Disease. The formulation is known for its stability profile and predictable absorption characteristics.

Intended Audience Notice: This announcement is intended for healthcare professionals, hospitals, and authorized importers involved in the treatment and management of Wilson’s disease.

Key Highlights:

  • Triokris™ (Trientine Dihydrochloride 250 mg) is now available via Named Patient import pathways
  • Supports patients with Wilson’s disease who are intolerant to first-line therapy
  • Supplied under full regulatory compliance with complete quality documentation
  • Backed by GDP-aligned global logistics and pharmacovigilance oversight

Commitment to Rare Disease Care

Addressing the importance of patient access, Mr. Praveen Sikri, Founder & CEO, and Mr. Bharat Sikri, Director of Ikris Pharma Network, stated:

“Our focus has always been on supporting physicians and hospitals managing complex and rare conditions. With Triokris, we are helping enable access to a globally trusted chelation therapy for patients living with Wilson’s Disease, through compliant and well-structured pathways.”

Through its global sourcing network and regulatory-compliant import pathways, Ikris Pharma Network facilitates access to essential therapies in alignment with the Drugs & Cosmetics Act, ensuring product authenticity, full documentation, and cold-chain integrity where required.

About Triokris™ (Trientine Dihydrochloride)

Triokris is an oral chelating agent used for the removal of excess copper from the body. It is typically considered in:

  • Patients with intolerance to D-Penicillamine
  • Patients requiring maintenance therapy
  • Clinical scenarios where a stable, predictable chelator is preferred

The formulation consists of 250 mg of Trientine Dihydrochloride, developed to meet internationally accepted quality standards. Triokris is not intended to replace the clinical judgment of healthcare professionals, and treatment decisions should always be guided by a physician experienced in managing Wilson’s Disease.

Strengthening Access Through Regulatory Compliance

Ikris Pharma Network operates under strict adherence to Indian regulatory frameworks, ensuring that medicines supplied under the Named Patient Import Program follow mandated approval processes, documentation, batch traceability, and patient safety safeguards.

The organization collaborates with global manufacturers and GDP-compliant logistics partners to maintain integrity from dispatch to delivery. Each supply is backed by relevant quality documents.

A Step Forward for the Wilson’s Disease Community

The introduction of Triokris underscores Ikris Pharma Network’s mission to improve treatment access for underserved patient populations. The company continues to work closely with hepatologists, neurologists, rare disease centers, and patient support groups to strengthen awareness and early management of Wilson’s Disease.

About Ikris Pharma Network

Ikris Pharma Network is a global pharmaceutical services organization specializing in Named Patient Access, Rare Disease Medicines, Generic Medicine Export, RLD/Comparator Drug Supply, and Clinical Trial Support. The company partners with hospitals, physicians, and leading pharmaceutical manufacturers across the world to enable compliant access to hard-to-find therapies worldwide.

The company operates from its global headquarters in India and has established offices in Belgium, Bulgaria, and Hong Kong, supported by two strategic pharmaceutical warehouses in Europe. Ikris ensures end-to-end regulatory compliance, GDP-aligned supply-chain operations, and robust pharmacovigilance practices across all markets it serves.

Safety Reporting Information:

For any suspected adverse events or side effects associated with the use of Triokris™, healthcare professionals and patients are encouraged to report them by contacting drugsafety@ikrispharmanetwork.com.

Reporting safety information supports ongoing pharmacovigilance activities and helps ensure the continued safe and appropriate use of the medicine.

Disclaimer:

This material is provided for informational purposes only. Triokris™ is supplied in accordance with applicable regulatory requirements. Treatment decisions must be made by qualified healthcare professionals based on individual patient needs.

Media Contact:

Ikris Pharma Network Pvt. Ltd.
Email:
info@ikrispharmanetwork.com
Website: www.ikrispharmanetwork.com
TOLL-FREE: 1800 1200 365

New Delhi [India], January 15: Over the last two decades after their celebrated collaboration on the successful thriller Double Deal, ace producer Ashvin Gidwani of AGP World and renowned filmmaker- actor-director Mahesh Manjrekar have reunited for Lovable Rascal, a theatrical production that has already resonated strongly with audiences. The play now returns for an exclusive Republic Day special performance on 26th January 2026 at 7:30 pm at Nehru Centre Auditorium, and on 28th February 2026 at 7:00 pm at Tata Theatre, NCPA, Mumbai.

‘Lovable Rascal’ is adapted from Manjrekar’s acclaimed Marathi play ‘Filter Coffee’, which has earned praise for blending the complexities of life seamlessly with relatable characters and everyday humour. AGP World’s Hinglish adaptation of the play, a layered tale of love, loss, and hidden truths waiting to be uncovered, goes thus Amruta, a widow and artist, leads a quiet life with her house-help and a paying guest until a mysterious presence disrupts her calm. What starts as a subtle intrusion soon sparks an unexpected connection, reigniting her art and long-buried emotions. But beneath the surface, loyalties blur and intentions shift.

Speaking about the collaboration, Gidwani expresses, “Mahesh is one of the finest storytellers in Indian cinema and theatre. I have seen him at work over the years and his understanding of the medium is fantastic. After ‘Double Deal’, we had often spoken about working together again, and ‘Lovable Rascal’ felt like the perfect project. It’s witty, heartwarming, and grounded in situations everyone can relate to. The response to the first two shows has been immensely encouraging. At AGP World, we’re committed to delivering meaningful yet entertaining theatre, and this play captures that essence.”

Manjrekar, whose repertoire spans across Hindi, Marathi, Tamil, and Telugu cinema, speaks warmly about his long-standing association with Ashvin Gidwani. “Working with Ashvin again after ‘Double Deal’ feels like reconnecting with an old rhythm,” he shares. “Our creative synergy has evolved from just collaborating to truly co-creating, where ideas flow freely and every character, every scene, is crafted with mutual trust,” he shares.

Having experienced many reinventions through his journey as an actor, writer, and director, Manjrekar sees ‘Lovable Rascal’ as yet another turning point. For him, this production is not just an adaptation but a reimagining of how he approaches theatre. “With ‘Lovable Rascal’, I wanted to retain the heart of ‘Filter Coffee’ while making it accessible and engaging for an English-speaking audience. ‘Lovable Rascal’ marks a reinvention in how I approach theatre itself, translating a deeply rooted Marathi sensibility into a language and style that connects globally, without losing its emotional core. It’s a challenge, but also an opportunity to grow, to experiment, and to bridge cultures through the universal language of storytelling. Sharing this story on Republic Day adds a meaningful layer to the experience.”

The cast of the play includes popular VJ Anusha Dandekar, celebrated for her work as an MTV VJ, television host, and performer across film and music, adding charm, energy, and modern sensibility to the stage; and Sumedh Mudgalkar, of ‘RadhaKrishn’ fame, a trained dancer who began his journey on dance reality shows before rising to prominence as an actor, bringing versatility and a layered emotional range to his role. They are joined by Jayesh Thakkar, Kuhu Singh, and Karan Bendre, combining seasoned performers with fresh talent in a dynamic ensemble.

For AGP World, Lovable Rascal continues its tradition of presenting impactful and high-quality theatre under Ashvin Gidwani’s leadership. With landmark productions such as Barff, Devdas – The Musical, The Scent of a Man, Sai The Musical, and Blame It on Bollywood, the company has consistently raised the bar for Indian theatre. Conceived over five years of creative dialogue, Lovable Rascal stands as a testament to AGP World’s commitment to meaningful storytelling, premium production values, and theatre that resonates across audiences and cultures.

Catch the exclusive performance of AGP World’s Lovable Rascal on 26th January 2026 at 7:30 pm, at Nehru Centre Auditorium, Worli, Mumbai, and on 28th February 2026 at 7:00 pm at Tata Theatre, NCPA.

Tickets available on BookMyShow.

For further enquiries, block bookings or information kindly contact enquiries@agpworld.com.